(Q34747527)

4 August 2017

Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

Kakkar VV

1

1 reference

4 August 2017

Djazaeri B

2

1 reference

4 August 2017

Fok J

3

1 reference

4 August 2017

Fletcher M

4

1 reference

4 August 2017

Scully MF

5

1 reference

4 August 2017

Westwick J

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 February 1982

1 reference

4 August 2017

1 reference

4 August 2017

284

1 reference

4 August 2017

6313

1 reference

4 August 2017

375-379

1 reference

Anti-Xa active heparin oligosaccharides

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

The problems of thrombosis in the deep veins of the leg

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

Plasma heparin: a unique, practical, submicrogram-sensitive assay

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

The relationship of molecular weight, and sulfate content and distribution to anticoagulant activity of heparin preparations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

The molecular-weight range of mucosal-heparin preparations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

The molecular-weight-dependence of the anti-coagulant activity of heparin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

Anticoagulant Activities of High and Low Molecular Weight Heparin Fractions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

A stable, radioactive substrate emulsion for assay of lipoprotein lipase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495962

The standardized normal Ivy bleeding time and its prolongation by aspirin

26 October 2018

1 reference

12 December 2020

Inhibition of the thrombin-fibrinogen reaction by heparin and purified cofactor

1 reference

12 December 2020

125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis

1 reference

12 December 2020

Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cultures

1 reference

12 December 2020

Anticoagulant Action of Heparin

1 reference

12 December 2020

The separation of active and inactive forms of heparin

1 reference

12 December 2020

The effect of antithrombin III on the activity of the coagulation factors VII, IX and X

1 reference

12 December 2020

Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection

1 reference

12 December 2020

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration

1 reference

12 December 2020

Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein

1 reference

12 December 2020

Anticoagulant activities of four unfractionated and fractionated heparins

1 reference

12 December 2020

Anticoagulant activities of lung and mucous heparins

1 reference

12 December 2020

Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina

1 reference

12 December 2020

Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin

1 reference

12 December 2020

Rapid radioimmunoassay of human fibrinopeptide A - removal of cross-reacting fibrinogen with bentonite

1 reference

12 December 2020

Identifiers

PMCID

1495962

1 reference

4 August 2017

1 reference